Milrinone Horizon 10mg/10 mL Concentrated Injection milrinone (as lactate)10mg/10 mL ampoule

Kraj: Australia

Język: angielski

Źródło: Department of Health (Therapeutic Goods Administration)

Składnik aktywny:

milrinone, Quantity: 10 mg

Dostępny od:

Generic Health Pty Ltd

INN (International Nazwa):

Milrinone

Forma farmaceutyczna:

Injection, concentrated

Skład:

Excipient Ingredients: water for injections; lactic acid; sodium hydroxide; glucose

Droga podania:

Intravenous

Sztuk w opakowaniu:

10 ampoules, 1 ampoule

Typ recepty:

(S4) Prescription Only Medicine

Wskazania:

- Milrinone Horizon Concentrated Injection is indicated for the short term (48 hours) intravenous therapy of severe congestive heart failure patients in intensive care and coronary care units not responding to other therapy (eg. digoxin, diuretics, vasodilators, including ACE inhibitors). The majority of experience with intravenous milrinone has been in patients receiving digoxin and diuretics. - Milrinone Horizon Concentrated Injection is also indicated for low output states following cardiac surgery, including weaning from cardio-pulmonary bypass pump.

Podsumowanie produktu:

Visual Identification: Clear, colourless to pale yellow sterile solution, practically free from visible particles.; Container Type: Ampoule; Container Material: Glass Type I Clear; Container Life Time: 3 Years; Container Temperature: Store below 25 degrees Celsius; Container Closure: Neither child resistant closure nor restricted flow insert

Status autoryzacji:

Licence status A

Data autoryzacji:

2013-11-29